Selective Laser Ablation of Methicillin-Resistant Staphylococcus Aureus with IgG Functionalized Multi-Walled Carbon
Abstract:
Severe infections caused by Methicillin-resistant Staphylococcus aureus (MRSA) and other bacteria are responsible for millions of deaths each year. One of the main objectives of future antibiotic strategies is to develop new anti-infective agents, which would be highly effective and drug-resistant (antimicrobial resistance being currently exhibited by MRSA), using specific antibodies conjugated to thermally active nanomaterials such as NIR-responsive photothermal contrast agents. Multi-walled carbon nanotubes (MWCNTs) covalently functionalized with immunoglobulin G (IgG, an antagonist of Staphylococcal protein A-SpA, which is a MRSA membrane associated protein) were selectively delivered (at various concentrations and incubation times) into MRSA bacteria. Following treatment, cultures were irradiated using an 808 nm 2 w laser diode. The post irradiation death rate ranged from 39.6% (for 1 mg/L) to 79.2% (for 50 mg/L) at 60 seconds (p < 0.001), while at 30 minutes, the death rate increased from 45.2% (1 mg/L) to 85.72% (50 mg/L), p < 0.001. Irradiated MRSAs treated with MWCNTs alone (control) for 60 seconds and 30 minutes, at concentrations ranging from 1 mg/L to 50 mg/L, resulted in significantly lower death rates (7.1-34.1% for 60 seconds, 11.7-48.8% for 30 minutes). Using IgG molecules bound to MWCNTs, followed by laser irradiation, we obtained a very efficacious nanoshell-mediated laser therapy of individual MRSA agents providing highly localized killing effects for IgG-MWCNTs targeted bacteria.
Insights
New therapy uses antibody-coated carbon nanotubes to kill Methicillin-resistant Staphylococcus aureus (MRSA) with near-infrared light. This targeted approach shows high efficacy against drug-resistant bacteria, offering a promising strategy against severe infections.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Infectious Diseases
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) causes millions of deaths annually.
- Antimicrobial resistance necessitates novel therapeutic strategies.
- Targeted drug delivery systems are crucial for combating resistant bacterial infections.
Purpose of the Study:
- To develop and evaluate a novel nanoshell-mediated therapy for MRSA.
- To investigate the efficacy of immunoglobulin G (IgG) conjugated multi-walled carbon nanotubes (MWCNTs) combined with photothermal therapy.
- To assess the targeted killing of MRSA using IgG-MWCNTs and near-infrared (NIR) laser irradiation.
Main Methods:
- Covalently functionalized MWCNTs with IgG, an antagonist of Staphylococcal protein A (SpA).
- Selective delivery of IgG-MWCNTs into MRSA bacteria at varying concentrations and incubation times.
- Irradiation of treated MRSA cultures using an 808 nm, 2W laser diode.
Main Results:
- Post-irradiation MRSA death rates ranged from 39.6% to 79.2% at 60 seconds and 45.2% to 85.72% at 30 minutes with increasing IgG-MWCNT concentrations (1-50 mg/L).
- Control groups (MWCNTs alone) showed significantly lower death rates (7.1-34.1% at 60s, 11.7-48.8% at 30 min).
- High efficacy was observed with IgG-MWCNTs and laser irradiation, demonstrating localized killing effects.
Conclusions:
- IgG-MWCNTs combined with NIR laser irradiation provide an effective nanoshell-mediated therapy against MRSA.
- This targeted approach offers highly localized killing effects, addressing the challenge of antimicrobial resistance.
- The study presents a promising strategy for developing new anti-infective agents against drug-resistant bacteria.
More Related Videos
07:07Endoscopy Guided Photoablation of Endometrial Cysts using a 980 nm Laser with a Contact Fiber in Mares
Published on: July 16, 2020
14:10Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010